Abpro Bio Co., Ltd. (KOSDAQ:195990)
1,312.00
+60.00 (4.79%)
At close: Apr 24, 2026
Abpro Bio Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3,899 | 15,495 | 18,856 | 16,951 | 53,961 |
Short-Term Investments | 1,183 | 6,163 | 944.31 | 796.04 | 430.25 |
Trading Asset Securities | - | - | 68.36 | 4,087 | - |
Cash & Short-Term Investments | 5,082 | 21,657 | 19,869 | 21,834 | 54,391 |
Cash Growth | -76.53% | 9.00% | -9.00% | -59.86% | 76.11% |
Accounts Receivable | 3,753 | 10,096 | 3,994 | 3,226 | 2,781 |
Other Receivables | 549.82 | 880.07 | 1,039 | 325 | 1,412 |
Receivables | 6,950 | 12,261 | 7,868 | 4,451 | 4,193 |
Inventory | 13,563 | 13,534 | 16,432 | 18,610 | 15,189 |
Prepaid Expenses | 358.8 | 598.48 | 37.43 | 40.62 | 520.3 |
Other Current Assets | 1,039 | 930.48 | 598.36 | 857.22 | 7,610 |
Total Current Assets | 26,993 | 48,981 | 44,804 | 45,793 | 81,903 |
Property, Plant & Equipment | 22,569 | 21,574 | 22,579 | 23,099 | 24,170 |
Long-Term Investments | 3,409 | 43,495 | 56,413 | 79,772 | 57,308 |
Goodwill | 9,014 | 13,496 | 8,004 | - | - |
Other Intangible Assets | 3,153 | 3,338 | 3,482 | 2,388 | 3,621 |
Long-Term Accounts Receivable | 19.43 | 112.81 | 252 | - | - |
Long-Term Deferred Tax Assets | 820.75 | 575.98 | 125.75 | - | - |
Other Long-Term Assets | 8,770 | 9,331 | 6,450 | 5,563 | 848.94 |
Total Assets | 74,777 | 141,263 | 142,110 | 156,646 | 167,884 |
Accounts Payable | 2,020 | 6,855 | 2,127 | 1,559 | 2,911 |
Accrued Expenses | 655.88 | 652.56 | 755.34 | 733.9 | 478.75 |
Short-Term Debt | 2,535 | 8,735 | 9,249 | 10,196 | 21,013 |
Current Portion of Long-Term Debt | 188.9 | 971.3 | 333.16 | - | - |
Current Portion of Leases | 492.43 | 383.92 | 367.48 | 303.02 | 214.43 |
Current Income Taxes Payable | - | - | 7.35 | - | - |
Other Current Liabilities | 2,497 | 3,418 | 5,085 | 3,217 | 5,143 |
Total Current Liabilities | 8,390 | 21,015 | 17,925 | 16,009 | 29,760 |
Long-Term Debt | 11,914 | 11,506 | 1,294 | - | - |
Long-Term Leases | 373.72 | 456.43 | 550.76 | 441.24 | 582.9 |
Long-Term Deferred Tax Liabilities | - | 213.32 | - | - | - |
Other Long-Term Liabilities | 70.16 | 59.75 | -0 | 0 | 0 |
Total Liabilities | 20,748 | 33,251 | 19,769 | 16,450 | 30,343 |
Common Stock | 142,345 | 142,345 | 142,345 | 136,845 | 130,102 |
Additional Paid-In Capital | 89,786 | 89,786 | 89,116 | 87,288 | 85,635 |
Retained Earnings | -177,484 | -128,564 | -112,935 | -87,193 | -79,070 |
Treasury Stock | -2.9 | -2.9 | -2.9 | -2.9 | -2.9 |
Comprehensive Income & Other | -614.97 | 4,448 | 3,817 | 3,259 | 876.8 |
Total Common Equity | 54,029 | 108,012 | 122,340 | 140,196 | 137,541 |
Shareholders' Equity | 54,029 | 108,012 | 122,340 | 140,196 | 137,541 |
Total Liabilities & Equity | 74,777 | 141,263 | 142,110 | 156,646 | 167,884 |
Total Debt | 15,504 | 22,053 | 11,794 | 10,940 | 21,811 |
Net Cash (Debt) | -10,422 | -395.59 | 8,075 | 10,893 | 32,581 |
Net Cash Growth | - | - | -25.88% | -66.56% | 67.16% |
Net Cash Per Share | -36.61 | -1.39 | 290.17 | 406.05 | 1208.38 |
Filing Date Shares Outstanding | 1,053 | 28.47 | 28.47 | 27.37 | 26.02 |
Total Common Shares Outstanding | 1,053 | 28.47 | 28.47 | 27.37 | 26.02 |
Working Capital | 18,603 | 27,966 | 26,879 | 29,783 | 52,143 |
Book Value Per Share | 51.29 | 3794.05 | 4297.35 | 5122.46 | 5285.92 |
Tangible Book Value | 41,862 | 91,178 | 110,854 | 137,808 | 133,920 |
Tangible Book Value Per Share | 39.74 | 3202.74 | 3893.89 | 5035.22 | 5146.75 |
Land | 11,740 | 11,740 | 10,000 | 10,000 | 10,000 |
Buildings | 11,631 | 9,873 | 18,480 | 18,494 | 18,607 |
Machinery | 5,588 | 5,499 | 6,996 | 7,352 | 7,218 |
Construction In Progress | - | 14.55 | 500 | - | 145.23 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.